TRIESENCE

Welcome to the Brand page for “TRIESENCE”, which is offered here for Ophthalmic pharmaceutical preparation for the treatment of macular edema;.

Its status is currently believed to be active. Its class is unavailable. “TRIESENCE” is believed to be currently owned by “NOVARTIS AG”.


Owner:
NOVARTIS AG
Owner Details
Description:
Ophthalmic pharmaceutical preparation for the treatment of macular edema;
Categories: OPHTHALMIC PHARMACEUTICAL PREPARATION